US Stock MarketDetailed Quotes
IPHA Innate Pharma
- 2.425
- 0.0000.00%
Trading Apr 22 12:05 ET
196.04MMarket Cap-25260P/E (TTM)
0.000High0.000Low326Volume2.400Open2.425Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)80.84MShares3.57052wk High3.55P/B131.79MFloat Cap1.81052wk Low--Dividend TTM54.35MShs Float11.950Historical High--Div YieldTTM0.00%Amplitude1.810Historical Low0.000Avg Price1Lot Size
About Innate Pharma Company
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and Fran?ois Romagné on September 23, 1999 and is headquartered in Marseille, France.
Company Profile
SymbolIPHA
Company NameInnate Pharma
Listing DateOct 17, 2019
Issue Price5.50
Founded1999
CEODr. Mondher Mahjoubi, M.D.
MarketNASDAQ
Employees179
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address117, Avenue de Luminy
CityMarseille
ProvinceProvence-Alpes-Cote-dAzur
CountryFrance
Zip Code13009
Phone33-4-30-30-30-30
Websitehttp://www.innate-pharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Mondher Mahjoubi, M.D.
- Chairman of the Executive Board and Chief Executive Officer
- 1.49M
- Nicola Beltraminelli
- Vice President and Chief Development Officer
- --
- Eric Vivier, PhD
- Senior Vice President and Chief Scientific Officer
- --
- Sonia Quaratino
- Chief Medical Officer and Executive Vice President
- --
- Frederic Lombard
- Chief Financial Officer
- --
- Yannis Morel, PhD
- Member of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development
- 637.85K
- Odile Laurent
- Vice President, Human Resources
- --
- Claire de Saint Blanquat
- Vice President, Legal and Corporate Affairs
- --
- Odile Belzunce
- Vice President, Compliance, IT and Portfolio Management
- --
- Henry Wheeler
- Vice President, Investor Relations and Communications
- --
- Herve Brailly, PhD
- Chairman of the Supervisory Board
- --
- Irina Staatz-Granzer, PhD
- Vice Chairman of the Supervisory Board
- 40.10K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg